James D. Neaton

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Bertram Pitt, Willem J. Remme, Faı̈ez Zannad et al. · New England Journal of Medicine · 2003 · 4.9K citations · Full text

Medicine, Cardiology, Pharmacology +17

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

Jeremiah Stamler, Olga Vaccaro, James D. Neaton et al. · Diabetes Care · 1993 · 4.1K citations

Medicine, Chronic Disease Prevention, Internal Medicine +14

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

David J. Gordon, Jeffrey L. Probstfield, Robert J. Garrison et al. · Circulation · 1989 · 3.2K citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

Bertram Pitt, Philip A. Poole‐Wilson, Robert Segal et al. · The Lancet · 2000 · 2K citations

Medicine, Cardiology, Internal Medicine +9